{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:29:35Z","timestamp":1789590575608,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.molmed.2004.02.004","type":"journal-article","created":{"date-parts":[[2004,3,14]],"date-time":"2004-03-14T05:07:16Z","timestamp":1079240836000},"page":"146-149","source":"Crossref","is-referenced-by-count":64,"title":["von Hippel\u2013Lindau tumor suppressor: not only HIF's executioner"],"prefix":"10.1016","volume":"10","author":[{"given":"Maria F.","family":"Czyzyk-Krzeska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw","family":"Meller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2004.02.004_BIB1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng1019","article-title":"Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia","volume":"32","author":"Ang","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.02.004_BIB2","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc885","article-title":"Molecular basis of the VHL hereditary cancer syndrome","volume":"2","author":"Kaelin","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2004.02.004_BIB4","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.02.004_BIB5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1097-2765(00)80233-6","article-title":"Formation of the VHL\u2013Elongin BC tumor suppressor complex is mediated by the chaperonin TRiC","volume":"4","author":"Feldman","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2004.02.004_BIB6","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/MCB.22.6.1947-1960.2002","article-title":"Diverse effects of mutations in exon II of the von Hippel\u2013Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity","volume":"22","author":"Hansen","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.02.004_BIB7","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1128\/MCB.23.9.3141-3151.2003","article-title":"The Hsp70 and Tric\/CCT chaperone system cooperate in vivo to assemble the VHL tumor suppressor complex","volume":"23","author":"Melville","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2004.02.004_BIB8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/embo-reports\/kvf028","article-title":"An intact NEDD8 pathway is required for cullin-dependent ubiquitylation in mammalian cells","volume":"3","author":"Ohh","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.molmed.2004.02.004_BIB9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","article-title":"Structure of the VHL\u2013elongin C\u2013elongin B complex: implications for VHL tumour suppressor function","volume":"284","author":"Stebbins","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.02.004_BIB10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","article-title":"Structural basis for the recognition of hydroxyproline in HIF-1\u03b1 by pVHL","volume":"417","author":"Hon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2004.02.004_BIB11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of HIF requires direct binding to the von Hippel- Lindau protein \u03b2-domain","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2004.02.004_BIB12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF-\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.02.004_BIB13","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.02.004_BIB14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2004.02.004_BIB15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng1254","article-title":"Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel\u2013Lindau protein","volume":"35","author":"Corn","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2004.02.004_BIB16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0968-0004(99)01529-7","article-title":"Regulatory subunit interactions of the 26S proteasome, a complex problem","volume":"25","author":"Ferrell","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.molmed.2004.02.004_BIB17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.2194290","article-title":"A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator","volume":"248","author":"Nelbock","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.molmed.2004.02.004_BIB18","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1074\/jbc.271.6.3112","article-title":"Identification, purification and characterization of a PA700-dependent activator of the proteasome","volume":"271","author":"DeMartino","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.15.2.310-326.2002","article-title":"Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi Sarcoma","volume":"15","author":"Barillari","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molmed.2004.02.004_BIB20","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1093\/emboj\/cdg410","article-title":"Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel\u2013Lindau protein","volume":"22","author":"Na","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2004.02.004_BIB21","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1073\/pnas.0436037100","article-title":"Von Hippel\u2013Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination","volume":"100","author":"Kuznetsova","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2004.02.004_BIB22","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/sj.onc.1203985","article-title":"The von Hippel\u2013Lindau tumor suppressor gene protects cells from UV\u2013mediated apoptosis","volume":"19","author":"Schoenfeld","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2004.02.004_BIB23","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1074\/jbc.M108269200","article-title":"Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel\u2013Lindau tumor suppressor protein","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB24","doi-asserted-by":"crossref","first-page":"43611","DOI":"10.1074\/jbc.M107880200","article-title":"The von Hippel\u2013Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C","volume":"276","author":"Okuda","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ncb899","article-title":"Regulation of microtubule stability by the von Hippel\u2013Lindau tumour suppressor protein pVHL","volume":"5","author":"Hergovich","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2004.02.004_BIB26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel\u2013Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2004.02.004_BIB27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","article-title":"von Hippel\u2013Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF","volume":"10","author":"Hoffman","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2004.02.004_BIB28","doi-asserted-by":"crossref","first-page":"29748","DOI":"10.1074\/jbc.M103093200","article-title":"MUF1, a novel elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase","volume":"276","author":"Kamura","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB29","doi-asserted-by":"crossref","first-page":"30109","DOI":"10.1074\/jbc.274.42.30109","article-title":"Von Hippel\u2013Lindau protein induces hypoxia-regulated arrest of tyrosine hydroxylase transcript elongation in pheochromocytoma cells","volume":"274","author":"Kroll","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB30","first-page":"1682","article-title":"Endogenous rat von Hippel\u2013Lindau tumor suppressor protein regulates catecholaminergic phenotype in PC12 cells","volume":"62","author":"Bauer","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2004.02.004_BIB31","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/emboj\/cdg173","article-title":"The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1a transcriptional activity","volume":"22","author":"Li","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2004.02.004_BIB32","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1074\/jbc.M210385200","article-title":"Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and VHL","volume":"278","author":"Lee","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2004.02.004_BIB33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1999.1767","article-title":"An important VHL tumor suppressor domain mediates Sp1-binding and self-association","volume":"266","author":"Cohen","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2004.02.004_BIB34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0968-0004(00)89080-5","article-title":"RASMOL: biomolecular graphics for all","volume":"20","author":"Sayle","year":"1995","journal-title":"Trends Biochem. Sci."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491404000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491404000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:22:51Z","timestamp":1550146971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491404000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S1471491404000528"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2004.02.004","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}